Open

Coming up

Don't miss

Replay


LATEST SHOWS

FASHION

Jewellery, a lucrative and rapidly growing sector of the fashion and luxury market

Read more

#THE 51%

Decision makers in Deauville: The 10th annual Women’s Forum

Read more

FOCUS

Tackling the taboo of infertility in Cameroon

Read more

THE WORLD THIS WEEK

Beyond Kobani: Jihadists resist strikes in Syria and gain ground in Iraq

Read more

THE INTERVIEW

Hassan Sheikh Mohamud, Somalian president

Read more

AFRICA NEWS

Nigeria: Reports of ceasefire between government and Boko Haram

Read more

MEDIAWATCH

Might #BringBackOurGirls have worked?

Read more

WEB NEWS

Video tackles prejudice towards West African as Ebola spreads

Read more

IN THE PAPERS

Aubry adds to Hollande's woes

Read more

Business

Stem Cells : Business at the Frontier of the Science

Text by FRANCE 24

Latest update : 2009-09-22

On top of main scientific stakes, embryonic stem cells research has also great economical outlets. But how French laboratories can compete with counterparts subjected to a legislation less restrictive ?

On the 9th of March of this year, Barack Obama relaunched the competition. Behind this science race, there is money to be made. In the arena of stem cell research, the United States wants to lead the pack.

 

In France, stem cell research is still waiting to get off the ground.

According to Mr Amir-Aslani, "Countries like the US or the UK have an advantage over France. The big pharmaceutical laboratories can sign contracts with research centres. These don't have the same restreints as their French counterparts."

 

Still, French laboratories are trying to get a piece of the pie. In Evry, in the South of the country, the I-Stem laboratory is one of the first to tackle stem cell research. Its director, Marc Peschanski, puts the blame for a slow start on the French lack of support for research.

 

Luckily for these French laboratories, foreign companies have arrived on the scene. This laboratory, I-Stem, has now got together with Roche. The Swiss pharmaceutical giant handed a 7,5 million Euro cheque to I-Stem. In exchange, the French laboratory has agreed to train the teams at Roche. This way, they get to take part in an international, and very competitive sector.

 

Swiss companies aren't alone in the stem cell therapy industry. The US, the UK, and China are players too. French researchers are still trying to get in the game and in order to do so, they are forced to look abroad.

 

 

A report by Stéphanie Paviet and Eric Josset.

 

 

 

 

 

 

 

 

Date created : 2009-09-22

COMMENT(S)